Ginsenosides from Panax ginseng differentially regulate lymphocyte proliferation

被引:46
作者
Cho, JY
Kim, AR
Yoo, ES
Baik, KU
Park, MH
机构
[1] UCL, Sch Med, Windeyer Inst Med Sci, Dept Immunol & Mol Pathol, London W1N 8AA, England
[2] Daewoong Pharmaceut Co, R&D Ctr, Dept Immunopharmacol, Songnam, South Korea
[3] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea
[4] Cheju Natl Univ, Sch Med, Dept Pharmacol, Cheju, South Korea
关键词
Panax ginseng; Araliaceae; ginsenosides; interleukin-2; lymphocyte proliferation;
D O I
10.1055/s-2002-32556
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
We have examined the immunosuppressive effects of representative ginsenosides (Rb(1), Rb(2), Re and Rg(1)) from Panax ginseng C. A. Meyer on CD4+ and CD8+ lymphocyte proliferation. Ginsenosides differentially modulated lymphocyte proliferation induced by concanavalin A (Con A), lipopolysaccharide (LPS), phytohema-glutinin (PHA) and interleukin-2 (IL-2). Thus, Rb(1) and Re significantly enhanced Con A-induced lymphocyte proliferation, whereas Rg(1) did not affect the proliferation. Interestingly, however, Rb(2) strongly blocked Con A, LPS and PHA-induced lymphocyte proliferation with the IC(50) values of 21.8, 29.0 and 24.0 muM, respectively. Moreover, Rb(2) inhibited Con A-stimulated IL-2 production with an IC(50) of 13.3 muM. In the IL-2-stimulated CD8+ T cell (CTLL-2) proliferation assay, Re and Rg(1) showed strong suppressive effects with IC(50) values of 57.5 and 64.7 muM, respectively. In contrast, neither Rb(1) nor Rb(2) did inhibit CTLL-2 cell proliferation at tested concentrations. These results suggest that ginsenosides from P. ginseng may modulate lymphocyte proliferation in a different manner.
引用
收藏
页码:497 / 500
页数:4
相关论文
共 21 条
[1]   Lignans from the rhizomes of Coptis japonica differentially act as anti-inflammatory principles [J].
Cho, JY ;
Kim, AR ;
Park, MH .
PLANTA MEDICA, 2001, 67 (04) :312-316
[2]   Savinin, a lignan from Pterocarpus santalinus inhibits tumor necrosis factor-α production and T cell proliferation [J].
Cho, JY ;
Park, J ;
Kim, PS ;
Yoo, ES ;
Baik, KU ;
Park, MH .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (02) :167-171
[3]   In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-α production and its modulation by known TNF-α antagonists [J].
Cho, JY ;
Yoo, ES ;
Baik, KU ;
Park, MH ;
Han, BH .
PLANTA MEDICA, 2001, 67 (03) :213-218
[4]   In vitro antiinflammatory effects of neolignan woorenosides from the rhizomes of Coptis japonica [J].
Cho, JY ;
Baik, KU ;
Yoo, ES ;
Yoshikawa, K ;
Park, MH .
JOURNAL OF NATURAL PRODUCTS, 2000, 63 (09) :1205-1209
[5]   In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa [J].
Cho, JY ;
Baik, KU ;
Jung, JH ;
Park, MH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 398 (03) :399-407
[6]   Immunomodulatory effect of arctigenin, a lignan compound, on tumour necrosis factor-α and nitric oxide production, and lymphocyte proliferation [J].
Cho, JY ;
Kim, AR ;
Yoo, ES ;
Baik, KU ;
Park, MH .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (11) :1267-1273
[7]  
CHO JY, 1998, YAKHAK HOEJI, V43, P296
[8]  
Correll Pamela H., 1997, Genes and Function, V1, P69
[9]   TYROSINE KINASES ARE INVOLVED WITH THE EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE IN HUMAN ARTICULAR CHONDROCYTES [J].
GENG, Y ;
MAIER, R ;
LOTZ, M .
JOURNAL OF CELLULAR PHYSIOLOGY, 1995, 163 (03) :545-554
[10]   Panax ginseng pharmacology: A nitric oxide link? [J].
Gillis, CN .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (01) :1-8